Copycat Sciences LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-in-Human Study of Orally Administered GS-441524 for COVID-19 (NCT04859244) | Copycat Sciences LLC | 2021-01-01 |
Track Copycat Sciences LLC automatically
Every clearance here is in the API, with alerts when new ones post.